Skip to main content
    I

    Intelligent Bio Solutions Inc. (INBS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.52
    -0.24 (-13.64%)

    Market Cap: $5.84M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Intelligent Bio Solutions Inc. (INBS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Intelligent Bio Solutions (INBS) to earn -$5.18 per share in the fiscal year ending Jun 30, 2027, on revenue of $6.10M. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$4.06.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 44.3%.

    Fiscal year ending Jun 30, 2027
    -$5.18
    EPS consensus, revenue $6.10M
    Fiscal year ending Jun 30, 2028
    -$4.06
    EPS consensus, revenue $8.80M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jun 30, 2027-$5.18-$5.18 to -$5.181$6.10M$6.10M to $6.10M1
    Jun 30, 2028-$4.06-$4.06 to -$4.061$8.80M$8.80M to $8.80M1

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Dec 31, 2026, at -$1.36, and highest for the quarter ending Jun 30, 2027, at -$1.20.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$1.36-$1.36 to -$1.361$1.40M$1.40M to $1.40M1
    Mar 31, 2027-$1.33-$1.33 to -$1.331$1.50M$1.50M to $1.50M1
    Jun 30, 2027-$1.20N/A3$1.84M$1.76M to $1.89M3

    Estimate Revisions

    No EPS estimate for the 4 periods below was revised in the last 30 days.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202700
    Fiscal year ending Jun 30, 202800
    Quarter ending Dec 31, 202600
    Quarter ending Mar 31, 202700

    EPS Trend

    The EPS consensus for the fiscal year ending Jun 30, 2027 has held over the last 60 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Jun 30, 2027-$5.18-$5.18-$5.18-$5.18N/AN/A
    Fiscal year ending Jun 30, 2028-$4.06-$4.06-$4.06-$4.06N/AN/A
    Quarter ending Dec 31, 2026-$1.36-$1.36-$1.36-$1.36N/AN/A
    Quarter ending Mar 31, 2027-$1.33-$1.33-$1.33-$1.33N/AN/A

    Frequently Asked Questions About INBS

    What is the INBS stock forecast?

    Consensus analyst estimates put Intelligent Bio Solutions's EPS at -$5.18 for the fiscal year ending Jun 30, 2027, on revenue of $6.10M.

    What EPS do analysts expect from INBS next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$5.18, with estimates from -$5.18 to -$5.18 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$4.06, with estimates from -$4.06 to -$4.06 from 1 analyst.

    What revenue do analysts expect from Intelligent Bio Solutions next year?

    For the fiscal year ending Jun 30, 2027, the consensus revenue estimate is $6.10M, with estimates from $6.10M to $6.10M. For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $8.80M, with estimates from $8.80M to $8.80M.

    How many analysts cover INBS?

    1 analyst estimates EPS for Intelligent Bio Solutions for the fiscal year ending Jun 30, 2027.